Table 1 Annual incidence of Antiphospholipid Syndrome stratified by gender

2000

1111

22,823,451

4.87

497

11,181,321

4.44

614

11,642,130

5.27

2001

1060

23,170,145

4.57

497

11,408,052

4.36

563

11,762,093

4.79

2002

1102

23,365,986

4.72

487

11,550,720

4.22

615

11,815,266

5.21

2003

1014

23,490,871

4.32

439

11,648,599

3.77

575

11,842,272

4.86

2004

1316

23,642,983

5.57

519

11,767,614

4.41

800

11,875,369

6.74

2005

1328

23,785,305

5.58

539

11,875,098

4.54

789

11,910,207

6.62

2006

1378

23,892,455

5.77

572

11,953,923

4.79

806

11,938,532

6.75

2007

1353

23,999,660

5.64

517

12,035,496

4.30

836

11,964,164

6.99

2008

1435

24,099,774

5.95

546

12,112,765

4.51

889

11,987,009

7.42

2009

1466

24,140,628

6.07

641

12,164,240

5.27

825

11,976,388

6.89

2010

1608

24,193,125

6.65

649

12,219,631

5.31

959

11,973,494

8.01

2011

1725

24,289,377

7.10

681

12,281,805

5.54

1044

12,007,572

8.69

2012

1687

24,373,355

6.92

680

12,348,656

5.51

1007

12,024,699

8.37

2013

1580

24,354,771

6.49

662

12,352,693

5.36

915

12,002,078

7.62

P for trend

<.0001

<.0001

<.0001